These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31385465)

  • 1. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
    Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
    Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
    Cao G; Liu J; Liu M
    J Epidemiol Glob Health; 2023 Jun; 13(2):344-360. PubMed ID: 37178451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.
    Liu Z; Jiang Y; Yuan H; Fang Q; Cai N; Suo C; Jin L; Zhang T; Chen X
    J Hepatol; 2019 Apr; 70(4):674-683. PubMed ID: 30543829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis and prediction of disease burden of cirrhosis and other chronic liver diseases due to alcohol use in China from 1990 to 2030].
    Zhu S; Chen ST; Jin YY; Lu SW; Zou FJ; Ma WJ; Zeng FF; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):185-191. PubMed ID: 38413055
    [No Abstract]   [Full Text] [Related]  

  • 5. Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends.
    Cao M; Xia C; Cao M; Yang F; Yan X; He S; Zhang S; Teng Y; Li Q; Tan N; Wang J; Chen W
    Cancer Biol Med; 2024 Jul; 21(8):679-91. PubMed ID: 39015006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in prevalence of liver cancer and etiology-specific liver cancer from 1990 to 2019.
    Yang C; Jia J; Yu Y; Lu H; Zhang L
    Clin Res Hepatol Gastroenterol; 2024 Oct; 48(8):102451. PubMed ID: 39174005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
    Cao G; Liu J; Liu M
    Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
    Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
    Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.
    Zhai M; Long J; Liu S; Liu C; Li L; Yang L; Li Y; Shu B
    Aging (Albany NY); 2021 Jan; 13(1):279-300. PubMed ID: 33436531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of time trends in the incidence of primary liver cancer between China and the United States: an age-period-cohort analysis of the Global Burden of Disease 2019.
    Zou Z; Zhang Z; Lu C; Wang H
    Chin Med J (Engl); 2022 Sep; 135(17):2035-2042. PubMed ID: 36103990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributable causes of liver cancer mortality and incidence in china.
    Fan JH; Wang JB; Jiang Y; Xiang W; Liang H; Wei WQ; Qiao YL; Boffetta P
    Asian Pac J Cancer Prev; 2013; 14(12):7251-6. PubMed ID: 24460283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status.
    Cao G; Jing W; Liu J; Liu M
    Hepatol Int; 2022 Dec; 16(6):1282-1296. PubMed ID: 36048317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomics and attributable etiology of primary liver cancer, 1990-2019.
    Xing QQ; Li JM; Dong X; Zeng DY; Chen ZJ; Lin XY; Pan JS
    World J Gastroenterol; 2022 Jun; 28(21):2361-2382. PubMed ID: 35800181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017.
    Liu Z; Suo C; Mao X; Jiang Y; Jin L; Zhang T; Chen X
    Cancer; 2020 May; 126(10):2267-2278. PubMed ID: 32201944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease.
    Rajbhandari R; Danford CJ; Chung RT; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2015 May; 41(10):928-38. PubMed ID: 25786514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.
    Li Y; Ou Z; Yu D; He H; Zheng L; Chen J; Chen C; Xiong H; Chen Q
    BMC Cancer; 2023 Jun; 23(1):598. PubMed ID: 37380957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.
    Huang DQ; Singal AG; Kono Y; Tan DJH; El-Serag HB; Loomba R
    Cell Metab; 2022 Jul; 34(7):969-977.e2. PubMed ID: 35793659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia.
    Alqahtani SA; Abaalkhail F; Alghamdi S; Bzeizi K; Al-Hamoudi WK; Paik JM; Henry L; Al-Judaibi B; Sanai FM; Younossi ZM
    Saudi J Gastroenterol; 2024 Sep; 30(5):310-318. PubMed ID: 38946635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
    Yao L; Lin S; Huang J; Wu Y
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.